Clinical Trial Update: Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update for anlotinib hydrochloride in advanced soft tissue sarcoma patients not receiving chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Anlotinib hydrochloride (anlotinib)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: UNKNOWN